HOME > 業績集 > Pre-treatment with LCZ696 an Orally Active Angiotensin Reseptor Neprilysin Inhibitor, Prevents Ischemic Brain Damage

Pre-treatment with LCZ696 an Orally Active Angiotensin Reseptor Neprilysin Inhibitor, Prevents Ischemic Brain Damage

2018年04月05日